NODAL and melanoma: A review of available NODAL expression data in cancer cells suggested the existence of distinct splice variants [10], all including the second exon of the gene but sometimes, notably in melanoma cell lines, lacking its third (and last) exon and therefore lacking the capacity to produce a functional ligand.